Sujata B Vyas, MD | |
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
(888) 988-2800 | |
Not Available |
Full Name | Sujata B Vyas |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 441 N Lakeview Ave, Anaheim, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194873091 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | A45527 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sujata B Vyas, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Sujata B Vyas, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
Scientists in New Zealand say many top cyclists may be putting their health at risk for no competitive gain by taking the doping drug pseudoephedrine.
The Australian Medical Association of Queensland (AMAQ) recently revealed that the state's health authorities are keeping the truth about waiting time for cancer patients under wraps.
Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions - but this requires an injection.
Oral health has been called the window to one's overall health, and a new national research effort led by the University of Alabama at Birmingham School of Dentistry aims to provide people on the frontline of oral health care - community dentists in private practice - the opportunity to be on the forefront of research that addresses day-to-day issues they face with patients. The effort not only could improve the nation's dental health but its overall health as well.
Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.
› Verified 4 days ago
Ms. Bich Ngoc Dang, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3033 W Orange Ave, Anaheim, CA 92804 Phone: 714-827-3000 Fax: 949-588-2199 | |
Ernesto P Gidaya, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1111 W La Palma Ave, Anaheim, CA 92801 Phone: 714-774-1450 Fax: 714-710-7741 | |
Roxanne S. Tagayun, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Donny Chung, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dr. Claudia Marie Nuno Garcia, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1741 W Romneya Dr, Ste B, Anaheim, CA 92801 Phone: 714-332-5000 Fax: 714-833-5007 | |
Nhat D. Le, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dorothy M Toung, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |